HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$2.07
+0.14 (+7.25%)
Open$2.01
Previous Close$1.93
Day High$2.09
Day Low$1.98
52W High$9.56
52W Low$1.75
Volume—
Avg Volume8.4K
Market Cap14.11M
P/E Ratio—
EPS$-3.51
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+823.7% upside
Current
$2.07
$2.07
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 993.6K | 3.25M | 5.84M |
| Net Income | -31,895,800 | -94,026,269 | 1.21M |
| Profit Margin | -3,209.8% | -3,049.3% | 20.8% |
| EBITDA | -32,450,684 | -100,976,579 | 1.81M |
| Free Cash Flow | — | — | 575.3K |
| Rev Growth | -69.5% | -69.5% | -9.0% |
| Debt/Equity | — | — | 0.79 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,168.88 | +0.34% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.65 | +0.07% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $151.72 | +1.48% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.87 | +0.47% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $73.00 | +2.34% | 11.5 | 30.15B |